biote Corp. (BTMD) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	183.5M	192.2M	197.2M	185.4M	165.0M
Cost of Revenue	73.0M	54.9M	58.1M	57.9M	54.6M
Gross Profit	110.5M	137.4M	139.1M	127.5M	110.4M
Operating Expenses
R&D Expense	—	—	—	—	—
SG&A Expense	111.1M	101.8M	107.5M	98.8M	171.1M
General & Admin Expense	32.4M	—	—	—	171.1M
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	(15.3M)	—	—	—	—
Total Operating Expenses	95.8M	101.8M	107.5M	98.8M	171.1M
Cost and Expenses	168.8M	156.7M	165.6M	156.7M	225.7M
Operating Income (EBIT)	14.8M	35.6M	31.6M	28.7M	(60.7M)
Non-Operating
Interest Income	—	—	—	—	—
Interest Expense	9.4M	11.0M	11.0M	6.4M	4.0M
Net Interest Income	(9.4M)	(11.0M)	(11.0M)	(6.4M)	(4.0M)
Other Non-Op Income/Expense	(4.5M)	2.0M	(30.6M)	(28.8M)	62.4M
Non-Operating Income (excl Interest)	(4.9M)	(13.0M)	19.6M	(10.1M)	(66.5M)
EBT (Pre-Tax Income)	10.3M	37.6M	1.0M	(123.0K)	1.7M
Income Tax Expense	3.2M	6.0M	970.0K	2.7M	388.0K
Bottom Line
Net Income	5.9M	27.0M	3.2M	3.3M	(969.0K)
Earnings from Cont. Ops	7.1M	31.6M	46.0K	(2.8M)	1.3M
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	5.9M	27.0M	3.2M	3.3M	(969.0K)
Per Share
Basic EPS	$0.17	$0.86	$0.09	$0.13	($0.12)
Diluted EPS	$0.12	$0.74	$0.09	$0.13	($0.12)
Revenue Per Share	$6.41	$6.14	$5.75	$7.21	$20.47
Shares
Basic Shares Outstanding	28.6M	31.3M	34.3M	25.7M	8.1M
Diluted Shares Outstanding	28.6M	36.7M	34.3M	25.7M	8.1M
Profitability Metrics
EBITDA	23.5M	52.2M	15.6M	39.5M	8.0M
D&A	3.8M	3.7M	3.6M	794.0K	2.2M
EBIT	19.6M	48.5M	12.0M	38.7M	5.8M

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026